Kira Raskina

Kira Raskina

Foundation Medicine Inc. - Cambridge / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4947123
-
person_outline Kira Raskina's MOST POPULAR ARTICLES
1-) Comparative effectiveness of immune checkpoint inhibitors vs chemotherapy by tumor mutational burden in metastatic castration-resistant prostate cancerRP Graf, V Fisher, J Weberpals, O Gjoerup, MB Tierno, RSP Huang, ...JAMA Network Open 5 (3), e225394-e225394, 2022102022
2-) Predictive genomic biomarkers of hormonal therapy versus chemotherapy benefit in metastatic castration-resistant prostate cancerRP Graf, V Fisher, J Mateo, OV Gjoerup, RW Madison, K Raskina, ...European urology 81 (1), 37-47, 2022102022
3-) Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast CarcinomaHS Rugo, K Raskina, AB Schrock, RW Madison, RP Graf, ES Sokol, ...Clinical Cancer Research 29 (6), 1056-1067, 2023182023
4-) Genomic biomarkers and genome-wide loss-of-heterozygosity scores in metastatic prostate cancer following progression on androgen-targeting therapiesAJ Zurita, RP Graf, G Villacampa, K Raskina, E Sokol, D Jin, ...JCO Precision Oncology 6, e2200195, 2022
5-) APOBEC Mutational Signatures in Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 …S Sammons, K Raskina, N Danziger, L Alder, AB Schrock, JM Venstrom, ...JCO Precision Oncology 6, e2200149, 2022